Finally, this was a cross-sectional examination of these biomarkers, especially focusing on whether there was a loss of correlation between the level of Aβ1–42 and Aβ1–40 and the level of T-tau and P-tau in AD. This evidence concerns the gene MAPT and Alzheimer disease.